Application no. and date | 10181317.8 (espacenet) (Federated) (European Patent Register), 20040730 | Patent/reg. no. and date | DK/EP 2275134, 20170215 | Publication date | 20110119 | Priority no. and date | FR 0309440, 20030731 | EP pub. no. and date |
EP 2275134 20110119 | Effective date | | Applicant/owner | Laboratoire Français du Fractionnement et des Biotechnologies, Zone d'Activité de Courtaboeuf, 3, avenue des Tropiques
91940 Les Ulis, FR | Applicant ref. no. | LFB EP2275134 | Inventor | Bourel, Dominique, 35, avenue Germaine
59110 La Madeleine, FR, DE ROMEUF, Christophe, 116, rue de la Bassée
59000 Lille, FR, BIHOREAU, Nicolas, 36 avenue Parrat
91400 Orsay, FR, NONY, Emmanuel, 59 rue Pajeaud
92160 Antony, FR, Jorieux, Sylvie, 17 Rue Molière
59650 Villeneuve d'Ascq, FR, Klein, Philippe, 6 rue Corbet
59000 Lille, FR, Gauchet, Christine, 32, rue des Mésanges
59320 Sedequin, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61P 37/02 (2006.01) , C07K 16/28 (2006.01) | Title | ANVENDELSE AF ADCC-OPTIMEREDE ANTISTOFFER TIL BEHANDLING AF SVÆKKEDE PATIENTER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|